TipRanks
AbSci (ABSI)
NASDAQ:ABSI
US Market
ABSI
AbSci
RESEARCH TOOLSreports
Want to see ABSI full AI Analyst Report?

AbSci (ABSI) Stock Forecast & Price Target

1,364 Followers
See the Price Targets and Ratings of:

ABSI Analyst Ratings

Strong Buy
9Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
Based on 9 analysts giving stock ratings to
AbSci
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ABSI Stock 12 Month Forecast

Average Price Target

$14.63
▲(51.87% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for AbSci in the last 3 months. The average price target is $14.63 with a high forecast of $20.00 and a low forecast of $10.00. The average price target represents a 51.87% change from the last price of $9.63.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","6":"$6","11":"$11","16":"$16","21":"$21"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$14.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$10.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,6,11,16,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,11.461538461538462,12.173076923076923,12.884615384615385,13.596153846153847,14.307692307692308,15.01923076923077,15.73076923076923,16.442307692307693,17.153846153846153,17.865384615384617,18.576923076923077,19.28846153846154,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,11.048076923076923,11.346153846153847,11.64423076923077,11.942307692307692,12.240384615384615,12.538461538461538,12.836538461538462,13.134615384615385,13.432692307692307,13.73076923076923,14.028846153846153,14.326923076923077,{"y":14.625,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,10.692307692307692,10.634615384615385,10.576923076923077,10.51923076923077,10.461538461538462,10.403846153846153,10.346153846153847,10.288461538461538,10.23076923076923,10.173076923076923,10.115384615384615,10.057692307692308,{"y":10,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.13,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.28,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.04,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.49,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.02,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.15,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.92,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.52,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.11,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.78,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.84,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.75,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$20.00Average Price Target$14.63Lowest Price Target$10.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ABSI
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$16
Buy
66.15%
Upside
Reiterated
10/20/26
Analyst Maintains Buy on AbSci as ABS-201’s Differentiated Profile Supports Unchanged $16 Price Target
KeyBanc Analyst forecast on ABSI
Scott Schoenhaus
KeyBanc
KeyBanc
$16→$20
Buy
107.68%
Upside
Reiterated
10/16/26
KeyBanc Sticks to Their Buy Rating for AbSci (ABSI)
J.P. Morgan Analyst forecast on ABSI
Brian Cheng
J.P. Morgan
J.P. Morgan
$14→$15
Buy
55.76%
Upside
Reiterated
10/12/26
Absci price target raised to $15 from $14 at JPMorganAbsci price target raised to $15 from $14 at JPMorgan
BTIG Analyst forecast on ABSI
Kambiz Yazdi
BTIG
BTIG
$16
Buy
66.15%
Upside
Reiterated
10/06/26
BTIG Remains a Buy on AbSci (ABSI)
TD Cowen Analyst forecast on ABSI
Brendan Smith
TD Cowen
TD Cowen
―
Buy
―
Reiterated
09/30/26
Analysts Are Bullish on Top Healthcare Stocks: Q32 Bio (QTTB), Veeva Systems (VEEV)
LifeSci Capital Analyst forecast on ABSI
Rami Katkhuda
LifeSci Capital
LifeSci Capital
$16
Buy
66.15%
Upside
Reiterated
09/24/26
Absci Maintained at Buy as Analyst Sees Significant Endometriosis Upside, Keeps $16 Price Target Unchanged
Needham Analyst forecast on ABSI
Gil Blum
Needham
Needham
$11
Buy
14.23%
Upside
Reiterated
09/23/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Morgan Stanley Analyst forecast on ABSI
Sean Laaman
Morgan Stanley
Morgan Stanley
$10
Hold
3.84%
Upside
Assigned
08/17/26
AbSci (ABSI) Receives a Hold from Morgan Stanley
JonesTrading Analyst forecast on ABSI
Debanjana Chatterjee
JonesTrading
JonesTrading
$13
Buy
34.99%
Upside
Reiterated
08/12/26
Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), AbSci (ABSI)
Truist Financial Analyst forecast on ABSI
Srikripa Devarakonda
Truist Financial
Truist Financial
$11→$17
Buy
76.53%
Upside
Reiterated
07/02/26
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (NASDAQ: ANNX), AbSci (NASDAQ: ABSI) and Omnicell (NASDAQ: OMCL)
Guggenheim Analyst forecast on ABSI
Vamil Divan
Guggenheim
Guggenheim
$15
Buy
55.76%
Upside
Reiterated
06/25/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Leerink Partners Analyst forecast on ABSI
Mani Foroohar
Leerink Partners
Leerink Partners
$12
Buy
24.61%
Upside
Initiated
06/04/26
Absci initiated with an Outperform at LeerinkAbsci initiated with an Outperform at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ABSI
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$16
Buy
66.15%
Upside
Reiterated
10/20/26
Analyst Maintains Buy on AbSci as ABS-201’s Differentiated Profile Supports Unchanged $16 Price Target
KeyBanc Analyst forecast on ABSI
Scott Schoenhaus
KeyBanc
KeyBanc
$16→$20
Buy
107.68%
Upside
Reiterated
10/16/26
KeyBanc Sticks to Their Buy Rating for AbSci (ABSI)
J.P. Morgan Analyst forecast on ABSI
Brian Cheng
J.P. Morgan
J.P. Morgan
$14→$15
Buy
55.76%
Upside
Reiterated
10/12/26
Absci price target raised to $15 from $14 at JPMorganAbsci price target raised to $15 from $14 at JPMorgan
BTIG Analyst forecast on ABSI
Kambiz Yazdi
BTIG
BTIG
$16
Buy
66.15%
Upside
Reiterated
10/06/26
BTIG Remains a Buy on AbSci (ABSI)
TD Cowen Analyst forecast on ABSI
Brendan Smith
TD Cowen
TD Cowen
―
Buy
―
Reiterated
09/30/26
Analysts Are Bullish on Top Healthcare Stocks: Q32 Bio (QTTB), Veeva Systems (VEEV)
LifeSci Capital Analyst forecast on ABSI
Rami Katkhuda
LifeSci Capital
LifeSci Capital
$16
Buy
66.15%
Upside
Reiterated
09/24/26
Absci Maintained at Buy as Analyst Sees Significant Endometriosis Upside, Keeps $16 Price Target Unchanged
Needham Analyst forecast on ABSI
Gil Blum
Needham
Needham
$11
Buy
14.23%
Upside
Reiterated
09/23/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Morgan Stanley Analyst forecast on ABSI
Sean Laaman
Morgan Stanley
Morgan Stanley
$10
Hold
3.84%
Upside
Assigned
08/17/26
AbSci (ABSI) Receives a Hold from Morgan Stanley
JonesTrading Analyst forecast on ABSI
Debanjana Chatterjee
JonesTrading
JonesTrading
$13
Buy
34.99%
Upside
Reiterated
08/12/26
Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), AbSci (ABSI)
Truist Financial Analyst forecast on ABSI
Srikripa Devarakonda
Truist Financial
Truist Financial
$11→$17
Buy
76.53%
Upside
Reiterated
07/02/26
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (NASDAQ: ANNX), AbSci (NASDAQ: ABSI) and Omnicell (NASDAQ: OMCL)
Guggenheim Analyst forecast on ABSI
Vamil Divan
Guggenheim
Guggenheim
$15
Buy
55.76%
Upside
Reiterated
06/25/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Leerink Partners Analyst forecast on ABSI
Mani Foroohar
Leerink Partners
Leerink Partners
$12
Buy
24.61%
Upside
Initiated
06/04/26
Absci initiated with an Outperform at LeerinkAbsci initiated with an Outperform at Leerink
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
ONCBeOne Medicines
IRLAIRulya Therapeutics
IDYAIDEAYA Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AbSci

3 Months
Debanjana ChatterjeeJonesTrading
Success Rate
8/13 ratings generated profit
62%
Average Return
+40.11%
Copying Debanjana Chatterjee's trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +40.11% per trade.
1 Year
Debanjana ChatterjeeJonesTrading
Success Rate
11/13 ratings generated profit
85%
Average Return
+106.38%
Copying Debanjana Chatterjee's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +106.38% per trade.
2 Years
Srikripa DevarakondaTruist Financial
Success Rate
8/9 ratings generated profit
89%
Average Return
+132.64%
Copying Srikripa Devarakonda's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +132.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ABSI Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
10
8
6
7
11
Buy
10
12
12
9
8
Hold
3
3
3
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
23
21
17
20
In the current month, ABSI has received 19 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ABSI average Analyst price target in the past 3 months is 14.63.
Each month's total comprises the sum of three months' worth of ratings.

ABSI Financial Forecast

ABSI Earnings Forecast

Next quarter’s earnings estimate for ABSI is -$0.19 with a range of -$0.22 to -$0.13. The previous quarter’s EPS was -$0.21. ABSI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ABSI has Performed in-line its overall industry.
Next quarter’s earnings estimate for ABSI is -$0.19 with a range of -$0.22 to -$0.13. The previous quarter’s EPS was -$0.21. ABSI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ABSI has Performed in-line its overall industry.

ABSI Sales Forecast

Next quarter’s sales forecast for ABSI is $664.00K with a range of $0.00 to $1.72M. The previous quarter’s sales results were $318.00K. ABSI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ABSI has Performed in-line its overall industry.
Next quarter’s sales forecast for ABSI is $664.00K with a range of $0.00 to $1.72M. The previous quarter’s sales results were $318.00K. ABSI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ABSI has Performed in-line its overall industry.

ABSI Stock Forecast FAQ

What is ABSI’s average 12-month price target, according to analysts?
Based on analyst ratings, AbSci’s 12-month average price target is 14.63.
    What is ABSI’s upside potential, based on the analysts’ average price target?
    AbSci has 51.87% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ABSI a Buy, Sell or Hold?
          AbSci has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
            What is AbSci’s price target?
            The average price target for AbSci is 14.63. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $20.00 ,the lowest forecast is $10.00. The average price target represents 51.87% Increase from the current price of $9.63.
              What do analysts say about AbSci?
              AbSci’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of ABSI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.